688236 春立医疗
2026/06 - 中期2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)3.9769.3894.3889.92711.861
总资产报酬率 ROA (%)3.3087.6483.5137.8719.602
投入资产回报率 ROIC (%)3.8579.0204.1689.49411.504

边际利润分析
销售毛利率 (%)64.56966.04166.62572.47676.026
营业利润率 (%)32.38828.90216.22125.31827.372
息税前利润/营业总收入 (%)32.33327.76114.21223.94026.357
净利润/营业总收入 (%)28.75526.06915.46922.98825.609

收益指标分析
经营活动净收益/利润总额(%)98.231107.02796.97296.94697.282
价值变动净收益/利润总额(%)4.8454.99115.5137.0694.820
营业外收支净额/利润总额(%)-1.223-0.1770.672-0.0232.366

偿债能力分析
流动比率 (X)6.5465.2055.1954.4414.664
速动比率 (X)5.3734.2794.1883.7994.228
资产负债率 (%)15.08518.41318.59321.10720.238
带息债务/全部投入资本 (%)-0.1010.0761.4362.2050.022
股东权益/带息债务 (%)-96,312.031127,129.0606,635.7274,295.122443,917.517
股东权益/负债合计 (%)562.631442.854437.607373.539394.121
利息保障倍数 (X)96.036-25.474-6.710-17.448-15.698

营运能力分析
应收账款周转天数 (天)103.25776.442139.503133.250133.163
存货周转天数 (天)647.635550.838659.443375.695262.096